Researchers are using AI to design molecules and plan experiments. Other programmes attempt to restore cell function, remove senescent cells or replace damaged tissue. Longevity Frontier follows the specific programmes and explains the evidence they produce.
The publication gives particular attention to molecular discovery and cell reprogramming. Development records sit alongside explanations of the mechanisms and investigations into the experimental results.
Editorial responsibility
The owner edits under the professional identity Dr T Smith, an organic chemist and experienced science educator. Initials are used to separate the publication from unrelated professional work.
The editorial method explains how sources are assessed and how AI tools assisted with this edition.
Commercial scope
The publication does not sell supplements or provide an affiliate ranking of interventions. It has no accounts, paid subscriptions or advertising integrations in this edition. Programme inclusion does not imply endorsement.
Read the editorial method or contact and corrections information.